NO985978L - Insulinpreparater som inneholder karbohydrater - Google Patents

Insulinpreparater som inneholder karbohydrater

Info

Publication number
NO985978L
NO985978L NO985978A NO985978A NO985978L NO 985978 L NO985978 L NO 985978L NO 985978 A NO985978 A NO 985978A NO 985978 A NO985978 A NO 985978A NO 985978 L NO985978 L NO 985978L
Authority
NO
Norway
Prior art keywords
carbohydrate
insulin preparations
preparations containing
containing carbohydrates
carbon atoms
Prior art date
Application number
NO985978A
Other languages
English (en)
Other versions
NO985978D0 (no
NO324276B1 (no
Inventor
Lone L Gstrup Kimer
Per Balschmidt
Steen Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO985978D0 publication Critical patent/NO985978D0/no
Publication of NO985978L publication Critical patent/NO985978L/no
Publication of NO324276B1 publication Critical patent/NO324276B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
NO19985978A 1996-06-20 1998-12-18 Vandige insulinpreparater som inneholder mannitol. NO324276B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK68496 1996-06-20
DK89996 1996-08-27
PCT/DK1997/000267 WO1997048413A1 (en) 1996-06-20 1997-06-19 Insulin preparations containing carbohydrates

Publications (3)

Publication Number Publication Date
NO985978D0 NO985978D0 (no) 1998-12-18
NO985978L true NO985978L (no) 1999-02-19
NO324276B1 NO324276B1 (no) 2007-09-17

Family

ID=26064448

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985978A NO324276B1 (no) 1996-06-20 1998-12-18 Vandige insulinpreparater som inneholder mannitol.

Country Status (16)

Country Link
EP (1) EP0910402B1 (no)
JP (2) JP4472027B2 (no)
KR (1) KR20000022030A (no)
CN (1) CN1198643C (no)
AT (1) ATE369146T1 (no)
AU (1) AU719361B2 (no)
BR (1) BR9709844A (no)
CA (1) CA2258099A1 (no)
CZ (1) CZ297682B6 (no)
DE (1) DE69737995T2 (no)
ES (1) ES2292189T3 (no)
HU (1) HUP9904156A3 (no)
IL (1) IL127365A0 (no)
NO (1) NO324276B1 (no)
PL (1) PL188736B1 (no)
WO (1) WO1997048413A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0911035A3 (en) * 1997-10-24 2002-08-21 Eli Lilly And Company Insoluble insulin compositions
EA200000453A1 (ru) 1997-10-24 2000-10-30 Эли Лилли Энд Компани Композиции нерастворимого инсулина
EP1396272A1 (en) * 1997-12-23 2004-03-10 Eli Lilly & Company Insoluble Insulin Compositions for Controlling Blood Glucose
US6531448B1 (en) 1997-12-23 2003-03-11 Eli Lilly And Company Insoluble compositions for controlling blood glucose
AU2827199A (en) * 1998-03-24 1999-10-18 Klavs Holger Jorgensen Novel preparation of protracted acting human insulin
GB9806462D0 (en) * 1998-03-26 1998-05-27 Glaxo Group Ltd Improved compositions for inhalation
EP1121145B1 (en) * 1998-10-16 2002-04-17 Novo Nordisk A/S Insulin preparations for pulmonary delivery containing menthol
ES2177323T3 (es) * 1998-10-16 2002-12-01 Novo Nordisk As Preparaciones de insulina concentradas estables para la administracionpor via pulmonar.
US6635617B1 (en) 1998-10-16 2003-10-21 Novo Nordisk A/S Insulin preparations for pulmonary delivery containing menthol
US6211144B1 (en) 1998-10-16 2001-04-03 Novo Nordisk A/S Stable concentrated insulin preparations for pulmonary delivery
CN100364499C (zh) * 2003-05-01 2008-01-30 日本株式会社Ltt生物医药 包含锌的缓释组合物、其制剂及其制备方法
US7884181B2 (en) * 2004-10-05 2011-02-08 Novo Nordisk A/S Pharmaceutical formulation comprising crystalline insulin and dissolved insulin
ES2391776T3 (es) 2004-11-22 2012-11-29 Novo Nordisk A/S Formulaciones solubles, estables conteniendo insulina con una sal de protamina
CN1931360B (zh) * 2006-09-22 2013-02-13 江苏万邦生化医药股份有限公司 双时相精蛋白锌胰岛素注射液(30%)及其制备方法
CN102007143B (zh) 2008-01-09 2015-08-26 塞诺菲-安万特德国有限公司 具有超延迟时效特征的新型胰岛素衍生物
CN102256618A (zh) 2008-10-17 2011-11-23 赛诺菲-安万特德国有限公司 胰岛素和glp-1激动剂的组合
PL2451437T3 (pl) 2009-07-06 2017-05-31 Sanofi-Aventis Deutschland Gmbh Wodne preparaty insuliny zawierające metioninę
NZ599847A (en) 2009-11-13 2013-09-27 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
WO2012028172A1 (en) 2010-08-30 2012-03-08 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
TWI780236B (zh) 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
JP6723921B2 (ja) * 2014-01-09 2020-07-15 サノフイＳａｎｏｆｉ インスリンアナログおよび／またはインスリン誘導体の、グリセリンを含まない安定化された医薬製剤
CN105960249B (zh) 2014-01-09 2021-03-16 赛诺菲 胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂
JP2020143105A (ja) * 2014-01-09 2020-09-10 サノフイＳａｎｏｆｉ インスリンアスパルトの安定化された医薬製剤
US9895423B2 (en) * 2014-01-09 2018-02-20 Sanofi Stabilized pharmaceutical formulations of insulin aspart
JP7173953B2 (ja) * 2014-01-09 2022-11-16 サノフイ インスリンアナログおよび／またはインスリン誘導体の安定化された医薬製剤
JP2020114861A (ja) * 2014-01-09 2020-07-30 サノフイＳａｎｏｆｉ インスリンアナログおよび／またはインスリン誘導体の、グリセリンを含まない安定化された医薬製剤
PE20171622A1 (es) 2014-12-12 2017-11-02 Sanofi Aventis Deutschland Formulacion de relacion fija de insulina glargina/lixisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
WO2017163159A1 (en) * 2016-03-21 2017-09-28 Wockhardt Limited Biphasic pharmaceutical composition of insulin human

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439181A (en) * 1981-01-26 1984-03-27 Regents Of The University Of Minnesota Polyol-hormone mixture for use in chronic parenteral hormone administration
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
WO1995000550A1 (en) * 1993-06-21 1995-01-05 Novo Nordisk A/S Aspb28 insulin crystals

Also Published As

Publication number Publication date
DE69737995T2 (de) 2008-04-24
NO985978D0 (no) 1998-12-18
KR20000022030A (ko) 2000-04-25
CA2258099A1 (en) 1997-12-24
AU719361B2 (en) 2000-05-04
ATE369146T1 (de) 2007-08-15
JP2009242400A (ja) 2009-10-22
CZ395798A3 (cs) 1999-05-12
IL127365A0 (en) 1999-10-28
WO1997048413A1 (en) 1997-12-24
CN1222084A (zh) 1999-07-07
DE69737995D1 (de) 2007-09-20
HUP9904156A3 (en) 2000-07-28
HUP9904156A2 (hu) 2000-06-28
CN1198643C (zh) 2005-04-27
JP4472027B2 (ja) 2010-06-02
CZ297682B6 (cs) 2007-03-07
PL330828A1 (en) 1999-06-07
NO324276B1 (no) 2007-09-17
AU3166597A (en) 1998-01-07
EP0910402A1 (en) 1999-04-28
JP2000513343A (ja) 2000-10-10
ES2292189T3 (es) 2008-03-01
PL188736B1 (pl) 2005-04-29
BR9709844A (pt) 1999-08-10
EP0910402B1 (en) 2007-08-08

Similar Documents

Publication Publication Date Title
NO985978L (no) Insulinpreparater som inneholder karbohydrater
ZA975470B (en) Insulin preparations containing naci.
EP1736147A3 (en) Non-chlorofluorocarbon aerosol formulations
PT620828E (pt) Derivados de ciclodextrinas que exibem uma melhor solubilidade em agua e sua utilizacao
NZ501066A (en) Pharmaceutical formulations containing voriconazole and sulphobutylether beta-cyclodextrin
NO934500L (no) Ikke-klorfluorcarbonaerosolformuleringer
DE69132407D1 (de) Aerosol arzneiformulierungen
DK0948965T3 (da) Stabile medicinske præparater indeholdende 4,5-epoxymorphinanderivater
DE3484997D1 (de) Zellstimulierendes mittel.
AU8463391A (en) Axial-flow blower
GB9806632D0 (en) Peptide factor
AU4667589A (en) High molecular weight human angiogenic factors
MY104520A (en) Polymyxin conjugates.
ES2110009T3 (es) Derivados de la estreptolisina o.
EP0293766A3 (en) Emulsified compositions
MX9805939A (es) Formas solidas de administracion, de liberacion instantanea y procesos para su produccion.
USD316191S (en) Chair
IT8921023A0 (it) Derivati di fosfati della mitomicina con una attivita' antitumorale e una ridotta tossicita'.
AU8342991A (en) Bipolar signal amplification or generation
ITBO910373A0 (it) Dispositivo per il controllo d'estremita' di articoli da fumo, in particolare sigarette.
IT8820113A0 (it) Derivati peptidici del3_aminodiidrotiofen_2_one, loro preparazione e impiego terapeutico.
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
IT8820245A0 (it) Palmitoil_fruttosio_1,6_difosfato, suo uso terapeutico e relativi metodi di preparazione.
IT1249060B (it) Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche.
IT8819959A0 (it) Derivati alcossibenzimidazolici farmacologicamente attivi eprocedimento di preparazione.